Pacira BioSciences, Inc. (PCRX)
Debt-to-capital ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 778,348 | 749,583 | 879,278 | 892,162 | 870,130 | 831,551 | 807,975 | 768,041 | 775,010 | 770,123 | 756,636 | 709,576 | 730,408 | 718,602 | 687,168 | 650,818 | 619,688 | 584,690 | 388,148 | 374,037 |
Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $778,348K)
= 0.00
The debt-to-capital ratio of Pacira BioSciences, Inc. has consistently been recorded as 0.00 across all quarters from March 31, 2020, to December 31, 2024. This indicates that the company has not utilized debt as a significant portion of its capital structure during this period. A debt-to-capital ratio of 0.00 signifies that the company's total debt is either very low or non-existent compared to its total capital, which includes both debt and equity. This data suggests that Pacira BioSciences has been relying more on equity financing rather than debt financing to fund its operations and investments. It also indicates a relatively low financial risk associated with debt obligations, as debt levels are minimal or negligible in relation to the company's capital base.
Peer comparison
Dec 31, 2024